Clinical trials
Glucose clinical trials
Below are recruiting glucose clinical trials, each written for real people, not researchers. We’re tracking 441 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06116149Recruiting
Healthy lifestyle program for new mothers in WIC clinics
This trial tests a lifestyle program for new mothers (up to 1 year after giving birth) who have obesity or had gestational diabetes. It runs in WIC clinics and aims to help you improve your health after pregnancy.
New Orleans, LouisianaAges 18 years+ - NCT06171412Recruiting
Peer mentoring to help Black and Latinx people with type 1 diabetes use CGM more
This study tests whether support from a peer mentor can help Black and Latinx adults with type 1 diabetes who currently use a continuous glucose monitor (CGM) less than half the time to use it more regularly. You'll join remote video sessions with a mentor who has experience with diabetes.
New Haven, ConnecticutAges 13–21 - NCT06192940Recruiting
Smart insulin pens and quality of life in diabetes
This study tests if smart insulin pens that connect to continuous glucose monitors can improve quality of life for people with diabetes who need help managing their treatment. If you use multiple daily injections, a glucose sensor, and rely on a healthcare provider, this trial may help find better ways to manage your condition.
Corbeil-Essonnes, FranceAges 18 years+ - NCT06234787Recruiting
Continuous glucose monitoring in ICU patients
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
MadridAges 18 years+ - NCT06260059RecruitingPhase 4
Jardiance for adults with congenital heart disease and reduced heart function
This study tests a medicine called Jardiance (an SGLT2 inhibitor) to see if it helps improve heart function in adults with congenital heart disease who have recently experienced a drop in their heart pumping ability. Participants will take the medication alongside standard heart failure treatments.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT06272136Recruiting
Non-invasive continuous glucose monitor study for diabetes
This trial tests a new non-invasive continuous glucose monitor that you wear on your wrist like a watch, without needing finger sticks. It is designed for people with type 1 or type 2 diabetes who use insulin or certain diabetes pills.
Neuss, Nordrhein-WestfallenAges 18–65 - NCT06283797Recruiting
Automated insulin early after type 1 diabetes diagnosis in kids
This trial tests whether starting automated insulin therapy soon after diagnosis helps children and teens with type 1 diabetes control their blood sugar better. It uses a system that automatically adjusts insulin delivery based on continuous glucose monitoring.
AngersAges 2–18 - NCT06310356Recruiting
Glucose sensor for gestational diabetes
This study tests whether a continuous glucose monitor (a small sensor that checks your blood sugar levels all day) can help women with gestational diabetes manage their blood sugar more easily. The goal is to see if it improves health for both mom and baby.
Sydney, CAMPBELLTOWN NSWAges 18 years+ - NCT06315725Recruiting
Artificial sweeteners and blood sugar in type 1 diabetes
This study tests whether artificial sweeteners affect blood sugar levels in people with type 1 diabetes. If you use an insulin pump and have well-controlled diabetes, you may be able to join.
Montreal, QuebecAges 18–45 - NCT06329544Recruiting
Study of a high-fructose diet and gut health
This trial tests how a high-fructose diet affects your gut bacteria and overall metabolic health. It is for people who already know they don't absorb fructose well (fructose malabsorbers) and want to understand how this sugar impacts their body.
New York, New YorkAges 25–45 - NCT06338124Recruiting
Lab tests to predict outcomes in sepsis patients
This study looks at whether certain blood test results can help predict how well people with sepsis will do. Sepsis is a serious infection that can affect the whole body. You may be able to join if you have sepsis and are over 18.
AsyutAges 18–70 - NCT06354088RecruitingPhase 1
Study of alpelisib for insulin resistance
This study tests a single dose of a drug called alpelisib (a PI3K inhibitor) to see how it affects insulin and blood sugar in people who are either insulin sensitive or insulin resistant. The goal is to understand why some people become resistant to insulin, which may help find new treatments for diabetes and related conditions.
New York, New YorkAges 18–70 - NCT06366399Recruiting
Timing of resistance exercise for weight management
This study tests if doing resistance exercises (like lifting weights) in the morning or afternoon is better for weight management. You may qualify if you are between 50 and 74 years old, are overweight but generally healthy, and have not been very active with strength training.
Salt Lake City, UtahAges 50–74 - NCT06373016Recruiting
Ketone drink study for stable bipolar disorder
This study tests whether a ketone drink can change how the body uses energy in people with bipolar disorder. It may help understand new ways to manage the condition.
Belmont, MassachusettsAges 18–45 - NCT06396871Recruiting
Blood cell study in metabolic diseases
This study looks at blood cells and factors in people with metabolic diseases like fatty liver, prediabetes, or type 2 diabetes. It aims to better understand these conditions by comparing them with healthy volunteers.
Dresden, SaxonyAges 18 years+ - NCT06399835RecruitingPhase 4
Comparing two diabetes drugs for blood sugar and heart health
This study tests a new diabetes medicine called Enavogliflozin against an older drug, Pioglitazone, to see which works better for lowering blood sugar and improving heart health. If you have type 2 diabetes, take metformin plus another pill, and your A1C is between 7 and 10.5, this study may be an option for you.
Seongnam-si, Gyeonggi-doAges 20–80 - NCT06401577Recruiting
Acute pancreatitis and diabetes risk study
This study looks at how acute pancreatitis affects blood sugar and the risk of developing diabetes. You'll wear a continuous glucose monitor (CGM) sensor and have metabolic tests to track changes over time.
Los Angeles, CaliforniaAges 18–75 - NCT06413069Recruiting
Can almonds help with prediabetes and fatty liver?
This study tests whether eating almonds daily can improve blood sugar and liver health in adults with prediabetes and non-alcoholic fatty liver disease (NAFLD). It might help if you have these conditions and want a natural way to support your health.
BerlinAges 35–70 - NCT06417840Recruiting
Testing a plant compound for blood sugar in pre-diabetes
This study tests whether a natural compound from plants can help lower blood sugar levels in people with pre-diabetes. It focuses on Asian Indian adults who are overweight and have slightly high blood sugar.
New DelhiAges 18–50 - NCT06427421Recruiting
Immune cells in children with recent type 1 diabetes
This study looks at immune cells in children who were recently diagnosed with type 1 diabetes. It involves one extra blood draw to better understand how the immune system attacks the pancreas. If you join, no new treatments are given—just observation and analysis of your child's immune cells.
ParisAges 6–18 - NCT06430684RecruitingEarly Phase 1
SGLT2 inhibitor trial for children with kidney disease
This trial tests a medication called SGLT2 inhibitor (a type of diabetes drug that may also help protect the kidneys) in children with chronic kidney disease. It aims to see if the drug is safe and easy to use in children ages 2–18 with moderate to severe kidney problems.
Chicago, IllinoisAges 12–25 - NCT06443645Recruiting
Protecting the heart during breast cancer treatment
This trial tests whether a diabetes medicine (SGLT2 inhibitor) can prevent heart damage caused by a common chemotherapy drug (anthracycline) in people with early-stage breast cancer. If you are newly diagnosed and about to start chemotherapy or have surgery, this study may be for you.
StrasbourgAges 18 years+ - NCT06457139Recruiting
Preventing type 2 diabetes after gestational diabetes
This study tests whether checking your blood sugar right after delivery can help prevent type 2 diabetes in women who had gestational diabetes. If your blood sugar is high, you may be able to get early support to keep you healthy.
Worcester, MassachusettsAges 18 years+ - NCT06463483Recruiting
Automated Insulin Delivery for People with Advanced Kidney Disease
This trial tests an automated insulin pump system for people with diabetes who also have advanced kidney disease. It may help manage blood sugar more easily.
LondonAges 18–70
Hear when a new Glucose trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for glucose?
- Yes. Clin2 currently lists 441 recruiting glucose studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a glucose trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a glucose trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.